AMaRC (Australasian Myeloma Research Consortium) Research Advisory Group Member

ALL-G Myeloma Working Group Scientific Meeting and Group Writing Lead

MM23 (SEALAND) – Phase III Randomised Trial of Selinexor and Lenalidomide Maintenance – Trial Management Committee

Australia/New Zealand Myeloma Ambassador Program

Wrote protocols for EVIQ: Weekly carfilzomib/dexamethasone; pomalidomide/bortezomib/dexamethasone; GRIFFIN RVD; RVD-lite; RVD-SWOG S0777.

Co-funding research project “Optimising Multiple Myeloma Services in NSW through the contribution of Myeloma Advanced Practice Nurses” by the NSW Myeloma Working Group